Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashley J. J., Levy G. Inhibition of diphenylhydantoin elimination by its major metabolite. Res Commun Chem Pathol Pharmacol. 1972 Sep;4(2):297–306. [PubMed] [Google Scholar]
- Cox P. J., Levin L. Novel metabolic products of cyclophosphamide in human urine. Biochem Pharmacol. 1975 Jun 15;24(11-12):1233–1235. doi: 10.1016/0006-2952(75)90068-4. [DOI] [PubMed] [Google Scholar]
- Farquhar D., Loo T. L., Gutterman J. U., Hersh E. M., Luna M. A. Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment. Biochem Pharmacol. 1976 Jul 1;25(13):1529–1535. doi: 10.1016/0006-2952(76)90072-1. [DOI] [PubMed] [Google Scholar]
- Gerber N., Arnold K. Studies on the metabolism of diphenylhydantoin in mice. J Pharmacol Exp Ther. 1969 May;167(1):77–90. [PubMed] [Google Scholar]
- Gerber N., Wagner J. G. Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation. Res Commun Chem Pathol Pharmacol. 1972 May;3(3):455–466. [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Matsubara T., Koike M., Touchi A., Tochino Y., Sugeno K. Quantitative determination of cytochrome P-450 in rat liver homogenate. Anal Biochem. 1976 Oct;75(2):596–603. doi: 10.1016/0003-2697(76)90114-7. [DOI] [PubMed] [Google Scholar]
- Migdalof B. H. Methods for obtaining drug time course data from individual small laboratory animals: serial microblood sampling and assay. Drug Metab Rev. 1976;5(2):295–310. doi: 10.3109/03602537609029981. [DOI] [PubMed] [Google Scholar]
- Mullen P. W., Foster R. W. Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations. J Pharm Pharmacol. 1979 Feb;31(2):100–104. doi: 10.1111/j.2042-7158.1979.tb13441.x. [DOI] [PubMed] [Google Scholar]
- Soyka L. F., Hunt W. G., Knight S. E., Foster R. S., Jr Decreased liver and lung drug-metabolizing activity in mice treated with Corynebacterium parvum. Cancer Res. 1976 Dec;36(12):4425–4428. [PubMed] [Google Scholar]